Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses
NIAID - National Institute of Allergy and Infectious Diseases
About This Grant
PROJECT SUMMARY/ABSTRACT Germinal centers (GCs) are sites where B cells engage in T cell-dependent selection and ultimately differentiate to antibody-secreting plasma cells or long-lived memory B cells, a process that generates high- quality antibodies and helps to provide protection against pathogens and maintain immunological memory. Previous studies have shown that GCs are hypoxic compared to surrounding tissues and further suggest that this hypoxic environment is crucial for GC B cell responses. However, the mechanisms by which germinal center hypoxia governs GC B cell selection and differentiation are not fully understood. Hypoxia induces generation of the metabolite L-2-hydroxyglutarate (L-2HG), an inhibitor of α-ketoglutarate (αKG) dependent dioxygenases, including ten-eleven translocation (TET) and Jumonji-C domain containing lysine (K) demethylase (KDM) enzymes. TET and KDM enzymes mediate DNA and histone demethylation, respectively, and are known to be critical regulators of B cell fate. In mice with B cell specific deletion of L-2HG dehydrogenase (L2HGDH), the enzyme that metabolizes L-2HG to αKG, I observed an expansion of GC B cells and skewing towards memory fates. However, it is unknown how L-2HG-directed epigenetic changes affect DNA and histone methylation at key B cell regulatory genes, and how these changes may contribute to GC B cell fate decisions. Based on these preliminary results, I hypothesize that L-2HG produced under germinal center hypoxia influences B cell fate decisions through epigenetic reprogramming. In Aim 1, I will determine the role of L-2HG in regulation of GC B cell differentiation and memory commitment. I will use genetic models of B cell specific L2hgdh deficiency and overexpression to study the effects of altered L-2HG levels on GC B cell differentiation and memory. I will also use an immunization-infection model of influenza A to examine the functional effects of enhanced L-2HG levels on immunological memory. In Aim 2, I will elucidate the mechanisms of L-2HG-mediated epigenetic reprogramming in B cells. Using CUT&Tag and whole genome bisulfide sequencing (WGBS), I will assess the effects of increased L-2HG levels on histone and DNA methylation and assess transcriptional changes with single-cell RNA sequencing. I will further test the effects of DNA methylation inhibition to rescue the transcriptional, epigenetic, and differentiation changes induced by L-2HG treatment in B cells. Together, these studies will provide clear genetic evidence for an important role of L-2HG in memory B cell lineage commitment and define the precise mechanisms by which L-2HG influences transcriptional and epigenetic states in B cells.
Grant Summary
Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $45K for university, nonprofit, healthcare org. Applications are due 2030-05-31 (open). Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $45K
2030-05-31
- 1Confirm your organization is eligible for Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses: Frequently Asked Questions
Who is eligible for the Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses?
Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses provide?
Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses provides up to $45K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses deadline?
Applications for Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses are due 2030-05-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses?
To apply for Hypoxia-associated L-2-hydroxyglutarate in regulation of germinal center responses, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.